Acumen Pharmaceuticals Inc (ABOS)
3.49
+0.01
(+0.29%)
USD |
NASDAQ |
May 03, 16:00
3.495
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Free Cash Flow (Quarterly): -8.328M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -8.328M |
September 30, 2023 | -12.91M |
June 30, 2023 | -11.67M |
March 31, 2023 | -10.18M |
December 31, 2022 | -11.24M |
September 30, 2022 | -9.264M |
June 30, 2022 | -6.504M |
March 31, 2022 | -8.308M |
Date | Value |
---|---|
December 31, 2021 | -3.665M |
September 30, 2021 | -7.696M |
June 30, 2021 | -4.27M |
March 31, 2021 | -2.37M |
December 31, 2020 | -2.857M |
September 30, 2020 | -1.283M |
June 30, 2020 | -1.494M |
March 31, 2020 | -1.816M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-12.91M
Minimum
Sep 2023
-1.283M
Maximum
Sep 2020
-6.491M
Average
-7.10M
Median
Free Cash Flow (Quarterly) Benchmarks
Accuray Inc | -6.342M |
Kezar Life Sciences Inc | -18.98M |
Akoya Biosciences Inc | -6.178M |
NovaBay Pharmaceuticals Inc | -0.316M |
Palatin Technologies Inc | -10.51M |